Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

TRAIL sensitize MDR cells to MDR-related drugs by down-regulation of P-glycoprotein through inhibition of DNA-PKcs/Akt/GSK-3β pathway and activation of caspases

28 Jul 2010

Abstract excerpt

BACKGROUND: The development of new modulator possessing high efficacy, low toxicity and high selectivity is a pivotal approach to overcome P-glycoprotein (P-gp) mediated multidrug resistance (MDR) in cancer treatment. In this study, we suggest a new molecular mechanism that TRAIL (tumor necrosis factor-related apoptosis-inducing ligand) down-regulates P-glycoprotein (P-gp) through inhibition of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cell death mechanisms and regulation
Share to Drug Transport and Resistance Mechanisms
Share to Immune Response and Inflammation

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 20663232
DOI: 10.1186/1476-4598-9-199

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 20 Oct 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

TRAIL sensitize MDR cells to MDR-related drugs by down-regulation of P-glycoprotein through inhibition of DNA-PKcs/Akt/GSK-3β pathway and activation of caspasesPMID 20663232Read ↗

Mechanism of multidrug resistance to chemotherapy mediated by P‑glycoprotein (Review)Semantic proximity Read ↗

Molecular targeting therapy of cancer: drug resistance, apoptosis and survival signalSemantic proximity Read ↗

p53-Induced Autophagy Regulates Chemotherapy and Radiotherapy Resistance in Multidrug Resistance Cancer CellsSemantic proximity Read ↗

Molecular and cytogenetic changes in multi-drug resistant cancer cells and their influence on new compounds testing.Semantic proximity Read ↗

Microparticles induce multifactorial resistance through oncogenic pathways independently of cancer cell typeSemantic proximity Read ↗

The different regulatory effects of p53 status on multidrug resistance are determined by autophagy in ovarian cancer cells.Semantic proximity Read ↗

Multidrug resistance in chronic myeloid leukaemia: how much can we learn from MDR–CML cell lines?Semantic proximity Read ↗

Sensitization of multidrug resistant human ostesarcoma cells to Apo2 Ligand/TRAIL-induced apoptosis by inhibition of the Akt/PKB kinaseSemantic proximity Read ↗

Chk1 Inhibitor MK-8776 Restores the Sensitivity of Chemotherapeutics in P-glycoprotein Overexpressing Cancer CellsSemantic proximity Read ↗

Strategies to Overcome or Circumvent P-Glycoprotein Mediated Multidrug ResistanceSemantic proximity Read ↗

New Insight into P-Glycoprotein as a Drug TargetSemantic proximity Read ↗

New Insight into P-Glycoprotein as a Drug TargetSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.